UK markets open in 5 hours 13 minutes
NIKKEI 225
38,253.98 +51.61 (+0.14%) HANG SENG
18,346.33 +32.47 (+0.18%) CRUDE OIL
79.29 +0.30 (+0.38%) GOLD FUTURES
2,318.80 -3.50 (-0.15%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,159.38 -912.05 (-1.82%)
Verastem, Inc. (VSTM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 11.42 |
| Open | 11.41 |
| Bid | 11.35 x 200 |
| Ask | 11.45 x 100 |
| Day's range | 11.09 - 11.63 |
| 52-week range | 4.68 - 15.12 |
| Volume | |
| Avg. volume | 139,162 |
| Market cap | 288.508M |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Andreas Halvorsen's Viking Global Investors LP Bolsters Position in Verastem Inc
The transaction, which took place on December 31, 2023, involved the acquisition of 75,537 shares at a trade price of $8.14 per share. This strategic move has expanded Viking Global's holding to a total of 2,531,829 shares in Verastem Inc, reflecting the firm's confidence in the company's future prospects.
- GuruFocus.com
Director Robert Gagnon Sells 9,204 Shares of Verastem Inc (VSTM)
On February 6, 2024, Robert Gagnon, a director at Verastem Inc, executed a sale of 9,204 shares of the company.
- Zacks
Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy
Verastem's (VSTM) avutometinib/Lumakras combination therapy gets the FDA's Fast Track designation to treat KRAS G12C-mutant metastatic NSCLC patients. The stock gains 8% in response.
© 2024 Yahoo. All rights reserved.